Predictors of Risk in Left Ventricular Non-Compaction
Long Term Registry of Patients With Left Ventricular Non-Compaction and Predictors of Adverse Outcomes
1 other identifier
observational
500
1 country
1
Brief Summary
The goal of this study is to learn more about the risk factors associated with left ventricular non-compaction (LVNC) and the predictors of adverse outcomes associated with LVNC. The main questions this study aims to answer are as follows.
- Are there any genetic mutations that impact the risk of LVNC patients developing ventricular arrhythmias?
- Does LV myocardial strain increase risk stratification in the LVNC population with or without genetic mutations?
- What are some of the determinants that cause LV dysfunction in LVNC?
- What are other risk stratifiers (ex. premature ventricular contraction (PVC) burden on Holter, non-sustained ventricular tachycardia (NSVT) on stress test) that lead to an outcome of ICD implantation? Participants will have their medical records accessed annually for a span of ten years, either prospectively or retrospectively depending on whether they are being actively followed by physicians at the Inherited Arrhythmia Clinic or not, to evaluate LVNC progression over time. This data will be stored in a large clinical registry with the London Heart Rhythm Program at the London Health Sciences Centre, University Hospital Campus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedFirst Posted
Study publicly available on registry
September 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2033
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2033
November 1, 2023
October 1, 2023
9.9 years
July 31, 2023
October 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Develop a large clinical registry linked with the Inherited Arrhythmia Clinic
The Inherited Arrhythmia Clinic is a subdivision of the London Heart Rhythm Program at University Hospital, London Health Sciences Centre. As such, data will not go offsite but will simply be stored in a local REDCap database.
Up to 10 years
Secondary Outcomes (3)
Identification of genetic mutations linked to LVNC
Up to 10 years
Identification of determinants that cause LV dysfunction
Up to 10 years
Identification of factors that lead to ICD implantation
Up to 10 years
Study Arms (2)
Retrospective Cohort
Individuals in this group were previously seen by physicians at the Inherited Arrhythmia Clinic at University Hospital, London Health Sciences Centre, yet are no longer being actively followed here anymore. These patients will have their data retrospectively obtained annually, ten years into the past, to collect data on key variables providing insight on LVNC progression over time.
Prospective Cohort
Patients being actively followed up by physicians at the Inherited Arrhythmia Clinic will be approached either in person or via e-mail for consent and enrollment into this study. These patients will have their medical charts accessed annually to collect data on key variables providing insight on LVNC progression over time.
Eligibility Criteria
Patients in this study have a confirmed diagnosis of LVNC. Specifically, those in the prospective cohort are being actively followed up by physicians at the Inherited Arrhythmia Clinic whereas those in the retrospective cohort are no longer being actively followed up.
You may qualify if:
- Patients must meet the following criteria in order to be included in the study.
- Have a confirmed diagnosis of LVNC (between 2010-2020 for patients in the retrospective cohort only)
- Be over 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Health Sciences Centre - University Hospital
London, Ontario, N6A5A5, Canada
Biospecimen
Genetic testing
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2023
First Posted
September 6, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
August 1, 2033
Study Completion (Estimated)
August 1, 2033
Last Updated
November 1, 2023
Record last verified: 2023-10